請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/102761完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 黃國彥 | zh_TW |
| dc.contributor.advisor | Kuo-Yen Huang | en |
| dc.contributor.author | 劉凡箴 | zh_TW |
| dc.contributor.author | Fan- Jhen Liu | en |
| dc.date.accessioned | 2026-07-16T16:10:42Z | - |
| dc.date.available | 2026-07-17 | - |
| dc.date.copyright | 2026-07-08 | - |
| dc.date.issued | 2026 | - |
| dc.date.submitted | 2026-06-30 | - |
| dc.identifier.citation | 1. Miyamoto, Y. and M. Ishii, Spatial heterogeneity and functional zonation of living tissues and organs in situ. J Biochem, 2024. 176(4): p. 271-276. doi: 10.1093/jb/mvae049
2. Bareham, B., M. Dibble, and M. Parsons, Defining and modeling dynamic spatial heterogeneity within tumor microenvironments. Curr Opin Cell Biol, 2024. 90: p. 102422. doi: 10.1016/j.ceb.2024.102422 3. Xiao, Y. and D. Yu, Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther, 2021. 221: p. 107753. doi: 10.1016/j.pharmthera.2020.107753 4. Grunwald, B.T., et al., Spatially confined sub-tumor microenvironments in pancreatic cancer. Cell, 2021. 184(22): p. 5577-5592 e18. doi: 10.1016/j.cell.2021.09.022 5. Giaquinto, A.N., et al., Breast Cancer Statistics, 2022. CA Cancer J Clin, 2022. 72(6): p. 524-541. doi: 10.3322/caac.21754 6. Yan, Y., et al., A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo. Front Oncol, 2021. 11: p. 669393. doi: 10.3389/fonc.2021.669393 7. Swain, S.M., et al., Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. Lancet Oncol, 2020. 21(4): p. 519-530. doi: 10.1016/S1470-2045(19)30863-0 8. Yoon, J. and D.Y. Oh, HER2-targeted therapies beyond breast cancer - an update. Nat Rev Clin Oncol, 2024. 21(9): p. 675-700. doi: 10.1038/s41571-024-00924-9 9. Phan, T.G. and P.I. Croucher, The dormant cancer cell life cycle. Nat Rev Cancer, 2020. 20(7): p. 398-411. doi: 10.1038/s41568-020-0263-0 10. Aguirre-Ghiso, J.A., Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer, 2007. 7(11): p. 834-46. doi: 10.1038/nrc2256 11. Quail, D.F. and J.A. Joyce, Microenvironmental regulation of tumor progression and metastasis. Nat Med, 2013. 19(11): p. 1423-37. doi: 10.1038/nm.3394 12. Sahai, E., et al., A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer, 2020. 20(3): p. 174-186. doi: 10.1038/s41568-019-0238-1 13. Elkholi, I.E., et al., Breast Cancer Metastatic Dormancy and Relapse: An Enigma of Microenvironment(s). Cancer Res, 2022. 82(24): p. 4497-4510. doi: 10.1158/0008-5472.CAN-22-1902 14. Fluegen, G., et al., Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol, 2017. 19(2): p. 120-132. doi: 10.1038/ncb3465 15. Balamurugan, K., HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer, 2016. 138(5): p. 1058-66. doi: 10.1002/ijc.29519 16. Bragado, P., et al., TGF-beta2 dictates disseminated tumour cell fate in target organs through TGF-beta-RIII and p38alpha/beta signalling. Nat Cell Biol, 2013. 15(11): p. 1351-61. doi: 10.1038/ncb2861 17. Di Martino, J.S., et al., A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. Nat Cancer, 2022. 3(1): p. 90-107. doi: 10.1038/s43018-021-00291-9 18. Naumov, G.N., et al., A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst, 2006. 98(5): p. 316-25. doi: 10.1093/jnci/djj068 19. Teng, M.W., et al., Immune-mediated dormancy: an equilibrium with cancer. J Leukoc Biol, 2008. 84(4): p. 988-93. doi: 10.1189/jlb.1107774 20. Risson, E., et al., The current paradigm and challenges ahead for the dormancy of disseminated tumor cells. Nat Cancer, 2020. 1(7): p. 672-680. doi: 10.1038/s43018-020-0088-5 21. Massague, J. and K. Ganesh, Metastasis-Initiating Cells and Ecosystems. Cancer Discov, 2021. 11(4): p. 971-994. doi: 10.1158/2159-8290.CD-21-0010 22. Longo, S.K., et al., Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics. Nat Rev Genet, 2021. 22(10): p. 627-644. doi: 10.1038/s41576-021-00370-8 23. Rao, A., et al., Exploring tissue architecture using spatial transcriptomics. Nature, 2021. 596(7871): p. 211-220. doi: 10.1038/s41586-021-03634-9 24. Moses, L. and L. Pachter, Museum of spatial transcriptomics. Nat Methods, 2022. 19(5): p. 534-546. doi: 10.1038/s41592-022-01409-2 25. Ståhl, P.L., et al., Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science, 2016. 353(6294): p. 78-82. doi: 10.1126/science.aaf2403 26. Rodrigues, S.G., et al., Slide-seq: A Scalable Technology for Measuring Genome-Wide Expression at High Spatial Resolution. Science, 2019. 363(6434): p. 1463–1467. doi: 10.1126/science.aaw1219 27. Stickels, R.R., et al., Highly sensitive spatial transcriptomics at near-cellular resolution with Slide-seqV2. Nat Biotechnol, 2021. 39(3): p. 313-319. doi: 10.1038/s41587-020-0739-1 28. Chen, A., et al., Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. Cell, 2022. 185(10): p. 1777-1792 e21. doi: 10.1016/j.cell.2022.04.003 29. Moffitt, J.R., et al., Molecular, spatial, and functional single-cell profiling of the hypothalamic preoptic region. Science, 2018. 362(6416). doi: 10.1126/science.aau5324 30. Eng, C.L., et al., Transcriptome-scale super-resolved imaging in tissues by RNA seqFISH. Nature, 2019. 568(7751): p. 235-239. doi: 10.1038/s41586-019-1049-y 31. Janesick, A., et al., High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis. Nat Commun, 2023. 14(1): p. 8353. doi: 10.1038/s41467-023-43458-x 32. Xu, Y., et al., BFAST: joint dimension reduction and spatial clustering with Bayesian factor analysis for zero-inflated spatial transcriptomics data. Brief Bioinform, 2024. 25(6). doi: 10.1093/bib/bbae594 33. Liu, B., Y. Li, and L. Zhang, Analysis and Visualization of Spatial Transcriptomic Data. Front Genet, 2021. 12: p. 785290. doi: 10.3389/fgene.2021.785290 34. Dries, R., et al., Giotto: a toolbox for integrative analysis and visualization of spatial expression data. Genome Biol, 2021. 22(1): p. 78. doi: 10.1186/s13059-021-02286-2 35. Hu, J., et al., SpaGCN: Integrating gene expression, spatial location and histology to identify spatial domains and spatially variable genes by graph convolutional network. Nat Methods, 2021. 18(11): p. 1342-1351. doi: 10.1038/s41592-021-01255-8 36. Zhao, E., et al., Spatial transcriptomics at subspot resolution with BayesSpace. Nat Biotechnol, 2021. 39(11): p. 1375-1384. doi: 10.1038/s41587-021-00935-2 37. Svensson, V., S.A. Teichmann, and O. Stegle, SpatialDE: identification of spatially variable genes. Nat Methods, 2018. 15(5): p. 343-346. doi: 10.1038/nmeth.4636 38. Aravind Subramanian, et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS, 2005. 102(43): p. 15545-15550. doi:10.1073/pnas.0506580102 39. Sonja H¨anzelmann, RobertCastelo, and a.J. Guinney, GSVA: geneset variation analysis for microarray and RNA-Seq data. BMC Bioinformatics, 2013. 14. doi: 10.1186/1471-2105-14-7 40. Barbie, D.A., et al., Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature, 2009. 462(7269): p. 108-12. doi: 10.1038/nature08460 41. Aibar, S., et al., SCENIC: single-cell regulatory network inference and clustering. Nat Methods, 2017. 14(11): p. 1083-1086. doi: 10.1038/nmeth.4463 42. Liang, Q., et al., Pathway centric analysis for single-cell RNA-seq and spatial transcriptomics data with GSDensity. Nat Commun, 2023. 14(1): p. 8416. doi: 10.1038/s41467-023-44206-x 43. Tian, L., J. Xiao, and T. Yu, A robust statistical approach for finding informative spatially associated pathways. Brief Bioinform, 2024. 25(6). doi: 10.1093/bib/bbae543 44. Silverman, B.W., Density Estimation for Statistics and Data Analysis. 1998, Boca Raton: Routledge. 45. Diggle, P.J., Statistical Analysis of Spatial and Spatio-Temporal Point Patterns. 3 ed. 2013, New York: Chapman and Hall/CRC. 46. Wand, M.P. and M.C. Jones, Kernel Smoothing. 1 ed. 1994, New York: Chapman and Hall/CRC. 47. Bithell, J.F., An application of density estimation to geographical epidemiology. Statistics in Medicine, 1990. 9(6): p. 691-701. doi: 10.1002/sim.4780090616 48. Worton, B.J., Kernel Methods for Estimating the Utilization Distribution in Home-Range Studies. Ecology, 1989. 70(1): p. 164-168. doi: 10.2307/1938423 49. Park, J., et al., Cell segmentation-free inference of cell types from in situ transcriptomics data. Nat Commun, 2021. 12(1): p. 3545. doi: 10.1038/s41467-021-23807-4 50. Liu, R., et al., Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces. Cancer Lett, 2024. 591: p. 216899. doi: 10.1016/j.canlet.2024.216899 51. D'Ignazio, L., M. Batie, and S. Rocha, Hypoxia and Inflammation in Cancer, Focus on HIF and NF-kappaB. Biomedicines, 2017. 5(2). doi: 10.3390/biomedicines5020021 52. Richbourg, N.R., et al., Outlook and opportunities for engineered environments of breast cancer dormancy. Sci Adv, 2024. 10(10): p. eadl0165. doi: 10.1126/sciadv.adl0165 | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/102761 | - |
| dc.description.abstract | 空間轉錄體技術可在保留組織結構下分析基因表現,有助於探討細胞空間分布與腫瘤微環境。然而如何解析空間中生物功能狀態分布仍具挑戰性。現有分析方法多延用自單細胞RNA定序流程,主要著重於單一基因表現或空間變異基因,即使結合 GSEA 或 GSVA 等路徑分析,在面臨基因表現訊號微弱或分布不均時,仍難以完整捕捉真實生物功能狀態的連續性空間變化,也缺乏在組織空間中明確辨識功能富集區域的能力。為克服上述限制,本研究提出一套以密度為基礎之分析框架 KDESH(KDE-based Spatial Hotspot Detection),用以辨識具有空間聚集特徵之生物功能路徑。此方法結合路徑活性評分、核密度估計(kernel density estimation)及置換檢定(permutation-based statistical testing),建立具統計基礎的空間功能分布模型。相較於傳統方法,KDESH不需依賴預先劃分之空間區域,而能捕捉功能途徑在空間上的連續性變化,並進一步辨識局部功能活性顯著富集的空間熱點(spatial hotspots)。此外,本方法亦可量化不同生物途徑之間的空間共定位(co-localization)。將KDESH應用於HER2 陽性乳癌空間轉錄體資料,並以腫瘤休眠作為具體的生物學探討案例。分析發現多數生物功能途徑在腫瘤組織中呈現顯著空間聚集現象,是腫瘤微環境的一項普遍特徵。另外,具有休眠特徵之腫瘤上皮細胞亦呈現顯著空間聚集 (p < 0.05),進一步分析發現,腫瘤休眠並非單一的細胞狀態,而是呈現空間與功能異質性。根據所處微環境條件,休眠細胞可區分為缺氧相關休眠熱點(hypoxia-associated dormancy hotspots, HDH)與常氧相關休眠熱點(normoxia-associated dormancy hotspots, NDH),代表不同的功能狀態與潛在調控機制。本研究建立的 KDESH 框架,可系統性解析腫瘤組織中的功能空間分布,並量化不同生物路徑之間的空間關聯,有助於對腫瘤微環境空間結構的理解,亦突顯微環境所驅動之功能異質性在癌症生物學中的重要性,並可作為未來空間腫瘤生物學研究與微環境導向治療策略發展之基礎。 | zh_TW |
| dc.description.abstract | Spatial transcriptomics can analyze gene expression while preserving tissue structure, which helps in exploring the spatial distribution of cells and the tumor microenvironment. However, analyzing the spatial distribution of biological functional states remains challenging. Current analytical methods mostly follow the single-cell RNA sequencing pipeline, mainly focusing on single-gene expression or spatially variable genes. Even when combined with pathway analysis such as GSEA or GSVA, they still struggle to fully capture the continuous spatial changes in true biological functional states when faced with weak or unevenly distributed gene expression signals, and cannot clearly identify functionally enriched regions in tissue. To address these limitations, we introduce a density-based analytical framework, KDESH. This framework combines pathway activity scoring, kernel density estimation, and permutation-based statistical testing to establish a statistically based spatial functional distribution model. Compared to traditional approaches, KDESH does not depend on predefined spatial regions but can capture continuous spatial changes in functional pathways and further identify spatial hotspots where local functional activity is significantly enriched. Furthermore, this framework can also quantify the spatial co-localization between different biological pathways. We applied KDESH to HER2-positive breast cancer spatial transcriptome data, using tumor dormancy as a case study. This analysis revealed that most biological functional pathways exhibit significant spatial aggregation in tumor tissues, indicating that such spatial functional organization is a common feature of the tumor microenvironment. Additionally, dormancy-like cells showed significant spatial aggregation (p < 0.05), indicating that these cells tend to accumulate in specific microenvironmental niches. Further analysis suggested that tumor dormancy is not a single cellular state, but rather exhibits spatial and functional heterogeneity. Based on their microenvironment, they can be classified into hypoxia-associated dormancy hotspots (HDH) and normoxia-associated dormancy hotspots (NDH), representing different functional states and potential regulatory mechanisms. Overall, the KDESH framework provides a novel approach to explore the spatial functional distribution within tumor tissues and to quantify the spatial relationships between different biological pathways. This deepens our understanding of the spatial architecture of the tumor microenvironment, highlights the importance of microenvironment-driven functional heterogeneity in cancer biology, and can be used as a foundation for future spatial tumor biology research and the development of microenvironment- guided therapy strategies. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2026-07-16T16:10:42Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2026-07-16T16:10:42Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 致謝 I
中文摘要 II Abstract IV CONTENTS VI LIST OF FIGURES VIII 1. Introduction 1 1.1.Spatial heterogeneity and tumor microenvironment 1 1.2.Clinical Challenge and Tumor Dormancy in HER2-positive Breast Cancer 2 1.3.Advances in spatial transcriptomics and remaining challenges 4 1.4.Limitations of the current spatial transcriptomics analysis 5 1.5.Kernel density estimation for spatial point patterns 7 1.6.Study objective 8 2. Materials and Methods 10 2.1.Patient sample and tissue processing 10 2.2.Spatial Transcriptomics Workflow and Library Preparation 11 2.3.Data Processing and Downstream Analysis 12 2.4.Density-based spatial functional analysis framework 14 2.4.1.Pathway activity scoring 14 2.4.2.KDESH: Two-dimensional Kernel Density Estimation for Spatial Hotspot Detection 16 2.4.3. Permutation test for Spatial Enrichment 17 2.4.4. Quantification of Spatial Colocalization Using Intersection-over-Union 18 2.5.Identification and Stratification of Dormancy 19 2.6.Differential gene expression analysis 20 3. Results 21 3.1.Overview of the density-based spatial functional analysis framework 21 3.2.Spatial organization of pathway-level functional programs in HER2-positive breast cancer 22 3.3.Dormancy-like epithelial cells exhibit spatial clustering and localized density hotspots 25 3.4.Dormancy hotspots exhibit distinct functional features 26 3.4.1.Dormancy hotspots are associated with hypoxia and stress-related functional programs 26 3.4.2.Dormancy exhibits hypoxia-dependent heterogeneity and distinct functional states 28 4. Discussion 30 5. Conclusion 35 Appendix 44 References 53 | - |
| dc.language.iso | en | - |
| dc.subject | 空間轉錄體學 | - |
| dc.subject | 核密度估計 | - |
| dc.subject | 熱點分析 | - |
| dc.subject | 空間共定位 | - |
| dc.subject | 腫瘤休眠 | - |
| dc.subject | KDESH | - |
| dc.subject | Spatial transcriptomics | - |
| dc.subject | KDESH | - |
| dc.subject | Kernel density estimation | - |
| dc.subject | hotspot | - |
| dc.subject | co-localization | - |
| dc.subject | Tumor dormancy | - |
| dc.title | 開發以密度為基礎的空間功能分析框架: 解析 HER2 陽性乳癌中的功能區域與腫瘤休眠異質性 | zh_TW |
| dc.title | Development of a Density-Based Spatial Functional Analysis Framework for Characterizing Tumor Functional Organization and Dormancy Heterogeneity in HER2-Positive Breast Cancer | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 114-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 楊泮池;張雅媗;蕭自宏 | zh_TW |
| dc.contributor.oralexamcommittee | Pan-Chyr Yang;Ya-Hsuan Chang;Tzu-Hung Hsiao | en |
| dc.subject.keyword | 空間轉錄體學; 核密度估計; 熱點分析; 空間共定位; 腫瘤休眠; KDESH | zh_TW |
| dc.subject.keyword | Spatial transcriptomics; KDESH; Kernel density estimation; hotspot; co-localization; Tumor dormancy | en |
| dc.relation.page | 56 | - |
| dc.identifier.doi | 10.6342/NTU202601536 | - |
| dc.rights.note | 同意授權(限校園內公開) | - |
| dc.date.accepted | 2026-07-01 | - |
| dc.contributor.author-college | 重點科技研究學院 | - |
| dc.contributor.author-dept | 精準健康學位學程 | - |
| dc.date.embargo-lift | 2031-06-30 | - |
| 顯示於系所單位: | 精準健康學位學程 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-114-2.pdf 未授權公開取用 | 3.04 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
